Biogen Inc BIIB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:03 AM EDT
272.77quote price arrow up+2.33 (+0.86%)
Volume
163,378
52 week range
223.25 - 363.92

...

Loading . . .
  • Open270.61
  • Day High273.83
  • Day Low270.60
  • Prev Close270.44
  • 52 Week High363.92
  • 52 Week High Date11/04/20
  • 52 Week Low223.25
  • 52 Week Low Date11/09/20

Key Stats

  • Market Cap41.553B
  • Shares Out152.34M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta0.44
  • YTD % Change11.73

KEY STATS

  • Open270.61
  • Day High273.83
  • Day Low270.60
  • Prev Close270.44
  • 52 Week High363.92
  • 52 Week High Date11/04/20
  • 52 Week Low223.25
  • 52 Week Low Date11/09/20
  • Market Cap41.553B
  • Shares Out152.34M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta0.44
  • YTD % Change11.73

RATIOS/PROFITABILITY

  • EPS (TTM)24.45
  • P/E (TTM)11.16
  • Fwd P/E (NTM)14.76
  • EBITDA (MRQ)5.46B
  • ROE (MRQ)33.28%
  • Revenue (MRQ)13.445B
  • Gross Margin (MRQ)86.57%
  • Net Margin (MRQ)30.16%
  • Debt To Equity (MRQ)69.40%

EVENTS

  • Earnings Date04/22/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Biogen Inc

There is no recent news for this security.

Profile

MORE
Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration...
Stelios Papadopoulos Ph.D.
Chairman
Michel Vounatsos
Chief Executive Officer
Michael McDonnell
Chief Financial Officer
Robin Kramer
Chief Accounting Officer
Susan Alexander Esq.
Executive Vice President
Address
225 Binney St
Cambridge, MA
02142-1031
United States

Top Peers

SYMBOLLASTCHG%CHG
REGN
Regeneron Pharmaceuticals Inc
500.80+6.16+1.25%
ALXN
Alexion Pharmaceuticals Inc
163.96+6.43+4.08%
GRFS
Grifols SA
17.84-0.42-2.33%
ILMN
Illumina Inc
392.02-9.94-2.47%
SGEN
Seagen Inc
145.65-3.99-2.67%